Sharm Derma Conference in collaboration with Novartis Pharma S.A.E. promotes better understanding of Psoriasis

During the Sharm Derma Congress taking place in Cairo, 24th to 27th October, coinciding with World Psoriasis Day, Novartis Pharma S.A.E (Novartis Egypt), in collaboration with the Egyptian Psoriasis Patient Society (under establishment), shed light on one of the world’s most prevalent autoimmune skin disorders, to help improve patients’ lives by promoting better understanding of the illness among the general public, as well as healthcare professionals.

Prof. Assem Farag, President of the Sharm Derma Congress said, “This edition of the Sharm Derma Conference marks the beginning of many initiatives we have underway to raise awareness of psoriasis, and take steps towards advancing patient care on many fronts. Despite its prevalence, psoriasis is one of the most misunderstood autoimmune skin disorders. Many people living with psoriasis experience anxiety, embarrassment and depression, they also face discrimination because others fear the condition is contagious. Our goal is to change that.”

“Psoriasis is a common, non-contagious, autoimmune skin disorder that affects almost 125 million people worldwide – about one adult in 501,” said Prof. Mahira El Sayed, former head ofAin Shams University Dermatology andVenereology Department, and Head of Egyptian Psoriasis Patient Society (under establishment).